Paul Tudor Jones’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$294K Sell
4,600
-13,400
-74% -$881K ﹤0.01% 3139
2026
Q1
$1.28M Buy
18,000
+13,500
+300% +$1.06M ﹤0.01% 2189
2025
Q4
$369K Sell
4,500
-11,300
-72% -$880K ﹤0.01% 2913
2025
Q3
$1.19M Sell
15,800
-50,800
-76% -$3.79M ﹤0.01% 2137
2025
Q2
$4.93M Buy
66,600
+59,800
+879% +$4.16M 0.01% 1096
2025
Q1
$549K Sell
6,800
-13,600
-67% -$1.17M ﹤0.01% 2226
2024
Q4
$1.59M Buy
20,400
+12,200
+149% +$1.04M 0.01% 1399
2024
Q3
$770K Buy
+8,200
New +$688K ﹤0.01% 1778
2024
Q2
Sell
-7,000
Closed -$636K 2495
2024
Q1
$636K Buy
+7,000
New +$582K ﹤0.01% 1540
2023
Q4
Sell
-20,200
Closed -$1.37M 2550
2023
Q3
$1.37M Buy
+20,200
New +$1.47M 0.01% 1128

Other funds holding GEHC

Paul Tudor Jones's GEHC Position: Q2 2026 in Review

Paul Tudor Jones sold out of GE HealthCare (GEHC) in Q2 2026, closing a stake of 15,415 shares — an estimated $1.01M sold.

Paul Tudor Jones first reported a position in GEHC in Q4 2024 and held it in 4 quarters. The position peaked at $2.93M in Q3 2025. 1,221 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Paul Tudor Jones reported no remaining GE HealthCare position as of Q2 2026 after selling out during the quarter.
  • Paul Tudor Jones sold 15,415 GE HealthCare shares in Q2 2026, an estimated $1.01M.
  • Paul Tudor Jones first reported a position in GE HealthCare in Q4 2024 and held it in 4 quarters.
  • Paul Tudor Jones's GE HealthCare position peaked at $2.93M in Q3 2025.
  • 1,221 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.